Nicotinamide Ribonucleoside

Mild Alzheimer Disease

Mclean HospitalEarly Phase 1

—

Rating in progress

Nicotinamide Ribonucleoside in Mild Alzheimer Disease is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active